## AES: The AES Corporation - XLU: Utilities

### Executive Summary

VALUE thesis: PEG 1.09 indicates fundamental undervaluation. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($12.82)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Is AES Corporation Stock Underperforming the Nasdaq?**
- Source: Barchart.com | 20251217T113650 | Somewhat-Bullish | Relevance: 100%
- The AES Corporation, a global energy company with a market cap of $9.9 billion, operates in power generation and utilities across the U.S. and internationally. While AES has outperformed the Nasdaq Composite in the short term (up 7.2% vs. 3.5% over three months), its year-to-date and 52-week performance lags behind the index significantly. Despite this, the company's strong Q3 2025 results and reaffirmation of guidance have fueled investor confidence, with analysts maintaining a "Moderate Buy" rating and projecting a 14.2% upside.

**2. Pharma co Organon inks VPPA with Schneider Electric for solar in Spain**
- Source: Renewables Now | 20251218T130537 | Somewhat-Bullish | Relevance: 61%
- Organon, a pharmaceutical company, has signed a virtual power purchase agreement (VPPA) with Schneider Electric. This agreement will enable Organon to source solar energy in Spain, supporting its sustainability goals. The deal highlights the increasing trend of corporations investing in renewable energy to reduce their carbon footprint.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Argus Research | $18 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Argus Research | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.3%)
- Blackrock Inc.: 6.4% (+1.5%)
- State Street Corpora: 6.1% (-0.3%)
- Ameriprise Financial: 4.9% (+3.1%)
- Morgan Stanley: 4.0% (+6.4%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.7% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.09 suggests fair value with growth premium. Forward P/E 5.9x attractive for 7% earnings growth. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $9.6B |
| Beta | 1.00 |
| 52W Range | $9.46 - $15.51 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.09 |
| Forward P/E | 5.9 |
| Current P/E | 6.3 |
| YoY Growth | 7.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.3% to -2.4% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). RSI neutral at 43. OFD pattern: -SUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.43% (CS: 24) | Weak |
| RSI_14 | 42.7 | Neutral |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 0.979x | Below |
| vs SMA50 | 0.965x | Below |
| vs SMA200 | 1.078x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $13.54
- **Stop Loss:** $12.82 (5.3% risk)
- **Target:** $14.98 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 833
- **Position Value:** $11,278.82
- **Portfolio %:** 11.28%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-26 (Est: $0.62)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.77 | $0.75 | -2.1% |
| 2025Q2 | $0.40 | $0.51 | +29.0% |
| 2025Q1 | $0.33 | $0.27 | -17.8% |
| 2024Q4 | $0.35 | $0.54 | +56.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*